Valuation (90%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 4.40 | -7.35 |
| PEG Ratio (TTM) | 0.48 | -0.01 |
| P/S Ratio (TTM) | 0.87 | 2.11 |
| P/B Ratio (TTM) | 0.67 | 1.58 |
| P/FCF Ratio (TTM) | 8.80 | 10.80 |
| Price to 5YR AVG Earnings Ratio | 5.93 | 4.71 |
| Price to 5YR AVG FCF Ratio | 14.04 | 8.71 |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.90% | 6.25% |
| ROE (TTM) | 15.37% | 9.25% |
| Net Profit Margin (TTM) | 19.67% | 16.46% |
| ROIC 5YR AVG | 7.25% | 13.23% |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 15.23% | 150.89% | 90.36% |
| Revenue | 8.94% | 31.46% | 33.92% |
| Net Income | 13.69% | 193.73% | 115.65% |
| Cash Flow | 28.50% | 59,272.09% | 35,558.84% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.61 | 1.72 |
| Quick Ratio (TTM) | 1.54 | 1.56 |
| D/E Ratio (TTM) | 1.00 | 0.67 |
| Interest Coverage (TTM) | 3.02 | 12.88 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 1.44 | 2.15 |
| LTL to 5YR AVG FCF | 17.20 | 3.23 |
| Shares Outstanding Growth 5YR AVG | 1.77% | 10.71% |